Reduced Toxicity, Myeloablative Conditioning With BU, Fludarabine, Alemtuzumab and SCT From Sibling Donors in Children With Sickle Cell Disease

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2014.84

Related search